Americas · General news · Toronto Star

Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor

Published by Toronto Star · Canada 8 h ago

Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced that the…

Read the full article on Toronto Star Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.thestar.com)

Also worth reading

CBC News

Federal government to announce new funding for 60 national sport organizations: sources

Global News

Why has B.C.’s snap election caught both main parties unprepared?

National Post

Here’s how much you need to earn to afford a home in Canada’s major cities

CTV News

CP24 hosts a final Toronto mayoral debate tonight. New exclusive polling shows it could shake up the election.

France 24 Amériques

Les vastes favelas du Brésil ont besoin de solutions de planification urbaine à long terme

Le Devoir